Recent News

Scientists evaluate strategy to treat aggressive breast cancer once it's spread to the brain

Scientists evaluate strategy to treat aggressive breast cancer once it's spread to the brain

UNC Lineberger's Carey Anders, MD, and Amanda Van Swearingen, PhD, senior research specialist at UNC Lineberger, presented preclinical findings at the American Association for Cancer Research Annual Meeting 2018 about a potential promising strategy for triple negative breast cancer brain metastases. They studied the PARP inhibitor, niraparib, in three models of triple negative breast cancer with alteration and loss-of-function changes in the BRCA1 gene.

Scientists evaluate strategy to treat aggressive breast cancer once it's spread to the brain - Read More…

For aggressive breast cancer in the brain, researchers clarify immune response

For aggressive breast cancer in the brain, researchers clarify immune response

In a preliminary study presented at the American Association for Cancer Research Annual Meeting 2018 in Chicago, researchers led by UNC Lineberger's Benjamin Vincent, MD, and Carey Anders, MD, revealed findings for what kind of immune response the body is staging against triple negative breast cancer that has spread to the brain. They hope they can use these findings to improve patient responses to drugs that work by unleashing the immune system against cancer.

For aggressive breast cancer in the brain, researchers clarify immune response - Read More…

UNC Lineberger faculty present at leading national cancer research meeting

UNC Lineberger faculty present at leading national cancer research meeting

UNC Lineberger clinicians and scientists shared their research findings at the American Association for Cancer Research's annual meeting in Chicago, April 14-18. The meeting draws tens of thousands cancer experts from around the world to learn about the latest developments in cancer research.

UNC Lineberger faculty present at leading national cancer research meeting - Read More…

Strategies identified to reverse obesity’s lingering, pro-cancer effects

Strategies identified to reverse obesity’s lingering, pro-cancer effects

In preliminary findings presented at the American Association for Cancer Research Annual Meeting 2018 in Chicago, researchers from the lab of UNC Lineberger's Stephen Hursting, PhD, reported on a number of studies examining possible ways to reverse obesity-linked biological changes.

Strategies identified to reverse obesity’s lingering, pro-cancer effects - Read More…